According to a Wall Street Journal report and sources familiar with the situation, pharma giant Merck is in talks to acquire Acceleron Pharma. The deal for Acceleron could be announced as early as this week said the sources, assuming that the discussions do not fall apart. Acceleron, a public American “clinical stage biopharmaceutical company” based … Continue reading “Merck is Reportedly Close to Buying Acceleron Pharma”
